Discover how SGLT2 inhibitors, originally developed for diabetes, provide remarkable cardiovascular benefits through multiple biological mechanisms.
Exploring how SGLT2 inhibitors, originally designed for diabetes, are now revolutionizing heart and kidney medicine through unexpected mechanisms.